The effect of FLT3 gene expression in senescence and telomere length regulation in AML cells with FLT3-ITD mutation

被引:0
|
作者
Hong, Jing Siou [1 ]
Yen, Jui Hung [1 ]
Wu, Chia Ling [2 ]
Chen, Pei Yi [1 ,2 ]
机构
[1] Tzu Chi Univ, Dept Mol Biol & Human Genet, Hualien, Taiwan
[2] Hualien Tzu Chi Hosp, Ctr Med Genet, Hualien, Taiwan
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P-1071
引用
收藏
页码:256 / 256
页数:1
相关论文
共 50 条
  • [1] FLT3-ITD Mutation in Relation to FLT3 Expression in Pediatric AML: A Prospective Study from India
    Sharawat, Surender Kumar
    Bakhshi, Radhika
    Vishnubhatla, Sreenivas
    Gupta, Ritu
    Bakhshi, Sameer
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2014, 31 (02) : 131 - 137
  • [2] Novel Small Molecule FLT3 Inhibitors for the Treatment of FLT3-ITD AML
    Melgar, Katelyn
    Walker, MacKenzie
    Jiang, Jian-kang
    Wilson, Kelli
    Mulloy, James C.
    Thomas, Craig J.
    Starczynowski, Daniel T.
    BLOOD, 2015, 126 (23)
  • [3] Role of Autophagy in Resistance of FLT3-ITD AML Stem Cells to FLT3 TKI Treatment
    Qiu, Shaowei
    Yan, Chengcheng
    Paterson, Andrew J.
    Li, Hui
    Anderson, Nick
    Abraham, Ajay
    He, Jianbo
    Shah, Mansi
    Agarwal, Puneet
    Yang, Jing
    Xie, Min
    Lu, Rui
    Welner, Rob S.
    Bhatia, Ravi
    BLOOD, 2019, 134
  • [4] HYPOXIA REGULATES FLT3-ITD EXPRESSION AND FUNCTION IN AML CELL-LINES HARBOURING A FLT3-ITD MUTATION
    Sironi, S.
    Wagner, M.
    Vasold, J.
    Drolle, H.
    Fiegl, M.
    ANNALS OF HEMATOLOGY, 2013, 92 : S12 - S13
  • [5] FLT3-ITD allelic ratio and HLF expression predict FLT3 inhibitor efficacy in adult AML
    Jarno Kivioja
    Disha Malani
    Ashwini Kumar
    Mika Kontro
    Alun Parsons
    Olli Kallioniemi
    Caroline A. Heckman
    Scientific Reports, 11
  • [6] FLT3-ITD allelic ratio and HLF expression predict FLT3 inhibitor efficacy in adult AML
    Kivioja, Jarno
    Malani, Disha
    Kumar, Ashwini
    Kontro, Mika
    Parsons, Alun
    Kallioniemi, Olli
    Heckman, Caroline A.
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [7] Effective Combination of CPX-351 with FLT3 Inhibitors in AML Blasts Harboring the FLT3-ITD Mutation
    Edwards, David K.
    Javidi-Sharifi, Nathalie
    Rofelty, Angela
    Rosenfeld, Claire
    Roth-Carter, Riley
    Tardi, Paul
    Mayer, Lawrence
    Tyner, Jeffrey W.
    BLOOD, 2016, 128 (22)
  • [8] Developing dual FLT3/MNK inhibitors to overcome sorafenib resistance in FLT3-ITD AML cells
    Zhao, Linxiang
    Zuo, Shuwei
    Xing, Kun
    Yue, Xiaoshuang
    Zhang, Huimin
    Zhang, Jingyi
    Waxman, Samuel
    Jing, Yongkui
    CANCER RESEARCH, 2024, 84 (06)
  • [9] Role of Enhanced Autophagy in Resistance of FLT3-ITD AML Stem Cells to FLT3 TKI Treatment
    Qiu, Shaowei
    Paterson, Andrew J.
    Abraham, Ajay
    He, Jianbo
    Shah, Mansi
    Agarwal, Puneet
    Mullen, Amanda K.
    Li, Hui
    Harris, Mason W.
    Anderson, Nicholas R.
    Bhatia, Ravi
    BLOOD, 2018, 132
  • [10] Discovery of a highly selective FLT3 inhibitor with specific proliferation inhibition against AML cells harboring FLT3-ITD mutation
    Heng, Hao
    Zhi, Yanle
    Yuan, Haoliang
    Wang, Zhijie
    Li, Hongmei
    Wang, Shuxian
    Tian, Jieyi
    Liu, Haichun
    Chen, Yadong
    Lu, Tao
    Ran, Ting
    Lu, Shuai
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, 163 : 195 - 206